UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Beaumont Financial Advisors LLC

Beaumont Financial Advisors LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,419 shares of the healthcare conglomerate’s stock after selling 272 shares during the quarter. Beaumont Financial Advisors LLC’s holdings in UnitedHealth Group were worth $2,326,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Robbins Farley bought a new position in UnitedHealth Group in the 3rd quarter valued at about $25,000. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC lifted its position in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the period. NewSquare Capital LLC raised its stake in shares of UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA boosted its stake in UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Up 2.5 %

Shares of UNH traded up $12.13 during midday trading on Friday, reaching $505.31. 3,822,618 shares of the stock were exchanged, compared to its average volume of 4,515,288. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company has a market cap of $465.86 billion, a price-to-earnings ratio of 30.72, a P/E/G ratio of 1.31 and a beta of 0.54. The firm has a 50 day simple moving average of $488.97 and a 200-day simple moving average of $515.22. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.26 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 27.74 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.49%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Analyst Ratings Changes

UNH has been the topic of a number of research reports. Oppenheimer reiterated an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Wells Fargo & Company reduced their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Truist Financial reaffirmed a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday. Finally, Morgan Stanley reduced their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.